Sitemap

Pages

• YU10 – 10th Anniversary
• Directions
• Home
• Library technologies
• Partnering, Collaboration & Pipeline
• Antibody Discovery
• Company
  • Team
  • Network & Partners
  • Career
• Project design & Licensing
• Bioinformatics / YUcare
• Contract Research
  • Antibody Discovery & Development
    • Hit Discovery
    • Lead Engineering
    • Lead Development
  • Antibody Engineering Contract Research
  • Antibody Humanization Contract Research
  • Libraries
• Antibody Engineering
• Antibody Humanization
• Events
  • Events Archive
• News
  • News Archive
• Legal notice
• Disclaimer
• Terms and conditions
• Sitemap
• New Technologies

Posts by category

• Category: Allgemein
  • Antibody Engineering and Therapeutics Asia – February 26.-28. 2019
• Category: Events
  • PEGS Boston – May 15-19, 2023
  • BIO International – June 5-8, 2023
  • Antibody Engineering & Therapeutics Europe – June 6-8, 2023
• Category: Events Archive
  • Deutsche Biotechnologie Tage – April 09.-10. 2019
  • BIO International Conference – March 05.-06. 2019
  • BIO Asia International Conference – March 05.-06. 2019
  • 9th Alpbach Workshop on Affinity Proteomics – March 11.-13. 2019
  • PEGS virtual – June 02-26, 2020
  • BIO Digital – June 08-12, 2020
  • BIO-EUROPE SPRING digital – March 22-25, 2021
  • PEGS BOSTON VIRTUAL – May 11-14, 2021
  • PEGS BOSTON – May 2-6, 2022
  • BioJapan – October 12-14, 2022
  • BIO-Europe – October 24-26, 2022
  • Discovery On Target – October 17-20, 2022
  • Antibody Therapeutics Xchange Europe 2022 – November 22, 2022
  • Keystone Meeting – February 19-22, 2023
  • Festival of the Biologics US – March 20-22, 2023
  • BIO Europe Spring – March 20-22, 2023
  • Deutsche Biotechnologietage – March 28-29, 2023
  • Swiss Biotech Day – April 24-25, 2023
• Category: Homepage Teaser
  • Bioinformatic Optimizations
  • The Power of in vitro Selection
  • Fully Human Therapeutic Antibodies
  • Antibody Engineering
  • Nature-derived Antibody Libraries
  • YUMAB® – Versatile Platform Concept
• Category: News
  • YUMAB celebrates 10th anniversary
  • Ymmunobio signs collaboration agreement with YUMAB
  • First hospitalized COVID-19 patient treated with COR-101 antibody
  • Human SARS-CoV-2 antibody COR-101 shows high efficacy in animal model
  • Mechanism of action for human SARS-CoV-2 antibody COR-101 identified
  • Innovation Award for CORAT’s COVID-19 antibody development
  • COVID-19: Media coverage of YUMAB’s activities
  • CORAT’s human COVID-19 antibody ready for clinical trials
• Category: News Archive
  • YUMAB announces new research & collaboration agreement with Merck
  • CORAT Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program
  • COVID-19: First SARS-CoV-2 neutralizing antibody discovered
  • COVID-19: Lower Saxony’s health minister visits YUMAB
  • YUMAB partner Enleofen enters joint development with Boehringer Ingelheim
  • YUMAB statement regarding the coronavirus crisis
  • COVID-19: Media coverage of YUMAB’s activities – Archive

Quizzes & Surveys

• Anniversary